CARBIZOLE 5 Caibimazole (5mg) Indication: Carbimazole is primarily used in the management of hyperthyroidism, including conditions such as Graves' disease. Mechanism of Action: Carbimazole works by inhibiting the production of thyroid hormones, particularly thyroxine (T4), by interfering with the function of the enzyme thyroperoxidase. Dosage: The dosage of Carbimazole is individualized based on the severity of hyperthyroidism and the patient's response to treatment. It is usually taken orally in tablet form. Administration: Carbimazole is typically taken with or without food. The frequency and duration of treatment depend on the specific needs of the patient and the healthcare provider's recommendations. Monitoring: Regular monitoring of thyroid function tests, including levels of thyroid hormones (T3 and T4) and thyroid-stimulating hormone (TSH), is important during Carbimazole treatment to adjust the dosage as needed. Adverse Effects: Common side effects of Carbimazole may include gastrointestinal symptoms, skin rashes, and changes in taste. Serious side effects such as agranulocytosis (a severe decrease in white blood cells) are rare but can occur. Contraindications and Precautions: Carbimazole is generally contraindicated in individuals with a known hypersensitivity to the drug. It should be used with caution in patients with certain blood disorders. Pregnancy and Breastfeeding: The use of Carbimazole during pregnancy may be associated with an increased risk of congenital anomalies. It is important for pregnant women or those planning pregnancy to discuss the potential risks and benefits with their healthcare provider. It's crucial for individuals taking Carbimazole to follow their healthcare provider's instructions, attend regular follow-up appointments, and report any unusual symptoms or side effects promptly. The information provided here is a general overview, and specific details may vary based on individual health conditions and medical history. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/carbizole-5-133893